You are here
Parenteral drug use
Hepatitis C - Parenteral drug use Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Claimant Report - Parenteral Drug Use - Hepatitis C [CR9042] Preliminary questions [10237]
10305 — the veteran has established the causal connection between the parenteral drug use and VEA service for the clinical onset of hepatitis C.
10318 — the veteran has established the causal connection between the parenteral drug use and operational service for the clinical onset of hepatitis C.
or
10307 — the veteran has established the causal connection between the parenteral drug use and eligible service for the clinical onset of hepatitis C.
Clinical onset and operational service [10318]
10314 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to operational service.
Clinical onset and eligible service [10307]
10315 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to eligible service.